Skip to main content
search
Main navigation
Home
About
About ACSH
Financials
Our Team
Donate
Publications
Media/Contact
Subscribe
Write For Us
risk vs. benefit
email
facebook
twitter
linkedin
pocket
reddit
print
4 Prescription Drugs People Love
In 2019, I wrote an article called "4 Prescription Drugs People Hate." It was rather popular.
Read more
Non-Opioid Drugs That Can Be Dangerous and Habituating. Should We Ban Them?
Just about any drug can be made to look bad, especially when its risks are considered in the absence of its benefits.
Read more
Subscribe to risk vs. benefit
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
DONATE
Popular articles
Volunteers Infected with COVID Virus: An Unethical Human Medical Experiment Goes Unnoticed
My Ozempic Journey: Lost in the Doldrums
ChatGPT Gets a Virology Lesson (and Sasses Off to Me)
Are Parasites Really to Blame for Type 1 Diabetes?
MindBodyGreen: Your One-Stop Shop for Wellness, or Woo?
ACSH Podcasts
Podcast: Is Science Too Political? If So, What Do We Do About It?
Podcast: The Profit Motive Behind 'Make America Healthy Again'
Podcast: Gender-Affirming Care for Kids: Ethical or Unacceptable?
Podcast: Have We Pinpointed a Cause of Long COVID?
Podcast: Pompous Pandemic Experts Know Less Than They Think
More podcasts
Latest from Henry
Medicare Cuts in Physicians' Compensation Threaten Healthcare for Seniors
The Media and I: Black Robes vs. White Coats
Mpox: Another Virus-Caused Public Health Emergency
The Media and I: Drug Reciprocity
More articles
Latest from Josh
ChatGPT Gets a Virology Lesson (and Sasses Off to Me)
Think *Your* Job Sucks? Epidemiologists Study Mpox by Collecting Used Condoms
Barbiturates: Old Workhorse Dragged Out For a Stupid Netflix Series
From Green to Gold: The Chemistry of Fall Leaf Colors
More articles
Latest from Chuck
Deadly Delays: Do Long Emergency Room Waits for Hip Surgery Put Lives at Risk?
Coercion or Choice? Reproductive Autonomy in Sickle Cell Disease Care
It’s All About SNAP
What I'm Reading (Oct. 3)
More articles